Potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases may already be out there in the form of drugs prescribed for other conditions.

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

The playbooks are designed to create a roadmap and offer guidance for more than 80% of U.S. health care organizations and ...

UW Health's Dr. Jeff Pothof discusses the FDA's authorization of the first artificial intelligence platform for breast cancer ...

ABUJA, NIGERIA / ACCESS Newswire / June 10, 2025 / In an era where healthcare disparities continue to challenge communities worldwide, five visionary pharmacists are making remarkable strides in revol ...

In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.

A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...

Investing.com -- Unicycive Therapeutics Inc (NASDAQ: UNCY) stock plunged 35.3% after the clinical-stage biotechnology company announced that the U.S. Food and Drug Administration (FDA) identified ...

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

FDA approves CLAIRITY BREAST, a new AI breast cancer prediction tool that helps doctors assess five-year risk from routine ...